在COVID-19全球大流行期间,帕金森病患者护理的潜在影响和挑战。

Journal of Clinical Movement Disorders Pub Date : 2020-08-08 eCollection Date: 2020-01-01 DOI:10.1186/s40734-020-00089-4
Ali Elbeddini, Anthony To, Yasamin Tayefehchamani, Cindy Wen
{"title":"在COVID-19全球大流行期间,帕金森病患者护理的潜在影响和挑战。","authors":"Ali Elbeddini, Anthony To, Yasamin Tayefehchamani, Cindy Wen","doi":"10.1186/s40734-020-00089-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>COVID-19 has made itself known to health care providers and families across the world in a matter of months. While primarily a respiratory disorder, it has also been shown to cause neurological symptoms, which can be a concern for Parkinson's disease (PD) patients. Although PD is not as common as other conditions such as cardiovascular diseases, it affects millions of patients around the world whose care has been affected by the global pandemic.</p><p><strong>Objectives: </strong>The aim of this review is to provide insight into the direct and indirect associations between COVID-19 and PD patient care.</p><p><strong>Results: </strong>Potential direct effects of COVID-19 include possible neurodegeneration, concerns of symptom self-management with over-the-counter (OTC) products and ICU challenges that can arise in PD patients. In addition, a subset of PD patients may be at higher risk of severe COVID-19 infection. The indirect effects of the pandemic are associated with the social distancing measures and disruptions in health care systems and PD clinical trials, which may negatively affect PD patients' mental wellbeing and create barriers in controlling their PD symptoms. On a more positive note, telemedical care is quickly emerging as a primary communication tool for virtual patient care. However, further research should be conducted to examine the applicability of telemedicine across the entire PD population, such as those with more severe symptoms living in less developed areas. With all the uncertainty during this time, it is hopeful to hear many promising COVID-19 treatments being researched, one of them being a PD drug therapy, amantadine.</p><p><strong>Conclusion: </strong>Hopefully, we can consider this pandemic an opportunity to strengthen the PD community and learn more about the impact of the SARS-COV-2 virus. This review provides an overview of the interaction between COVID-19 and PD patients and future investigational retrospective studies are suggested to validate the observations.</p>","PeriodicalId":15374,"journal":{"name":"Journal of Clinical Movement Disorders","volume":"7 ","pages":"7"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40734-020-00089-4","citationCount":"23","resultStr":"{\"title\":\"Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic.\",\"authors\":\"Ali Elbeddini, Anthony To, Yasamin Tayefehchamani, Cindy Wen\",\"doi\":\"10.1186/s40734-020-00089-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>COVID-19 has made itself known to health care providers and families across the world in a matter of months. While primarily a respiratory disorder, it has also been shown to cause neurological symptoms, which can be a concern for Parkinson's disease (PD) patients. Although PD is not as common as other conditions such as cardiovascular diseases, it affects millions of patients around the world whose care has been affected by the global pandemic.</p><p><strong>Objectives: </strong>The aim of this review is to provide insight into the direct and indirect associations between COVID-19 and PD patient care.</p><p><strong>Results: </strong>Potential direct effects of COVID-19 include possible neurodegeneration, concerns of symptom self-management with over-the-counter (OTC) products and ICU challenges that can arise in PD patients. In addition, a subset of PD patients may be at higher risk of severe COVID-19 infection. The indirect effects of the pandemic are associated with the social distancing measures and disruptions in health care systems and PD clinical trials, which may negatively affect PD patients' mental wellbeing and create barriers in controlling their PD symptoms. On a more positive note, telemedical care is quickly emerging as a primary communication tool for virtual patient care. However, further research should be conducted to examine the applicability of telemedicine across the entire PD population, such as those with more severe symptoms living in less developed areas. With all the uncertainty during this time, it is hopeful to hear many promising COVID-19 treatments being researched, one of them being a PD drug therapy, amantadine.</p><p><strong>Conclusion: </strong>Hopefully, we can consider this pandemic an opportunity to strengthen the PD community and learn more about the impact of the SARS-COV-2 virus. This review provides an overview of the interaction between COVID-19 and PD patients and future investigational retrospective studies are suggested to validate the observations.</p>\",\"PeriodicalId\":15374,\"journal\":{\"name\":\"Journal of Clinical Movement Disorders\",\"volume\":\"7 \",\"pages\":\"7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/s40734-020-00089-4\",\"citationCount\":\"23\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Movement Disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s40734-020-00089-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Movement Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40734-020-00089-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 23

摘要

背景:在短短几个月内,COVID-19已被世界各地的卫生保健提供者和家庭所知。虽然主要是一种呼吸系统疾病,但它也被证明会引起神经系统症状,这可能是帕金森病(PD)患者关注的问题。尽管PD不像心血管疾病等其他疾病那样常见,但它影响着全球数百万患者,他们的护理受到全球大流行的影响。目的:本综述的目的是深入了解COVID-19与PD患者护理之间的直接和间接关联。结果:COVID-19的潜在直接影响包括可能的神经退行性变、使用非处方(OTC)产品进行症状自我管理的担忧以及PD患者可能出现的ICU挑战。此外,一部分PD患者可能有更高的COVID-19严重感染风险。大流行的间接影响与社会距离措施以及医疗保健系统和PD临床试验的中断有关,这可能会对PD患者的心理健康产生负面影响,并在控制PD症状方面造成障碍。从积极的方面来看,远程医疗正在迅速成为虚拟患者护理的主要通信工具。然而,需要进一步的研究来检验远程医疗在整个PD人群中的适用性,例如那些生活在欠发达地区的症状更严重的人群。在这段时间里,由于所有的不确定性,我们希望听到许多有前途的COVID-19治疗方法正在研究中,其中一种是PD药物治疗金刚烷胺。结论:希望我们可以将这次大流行视为加强PD社区并更多地了解SARS-COV-2病毒影响的机会。本文综述了COVID-19与PD患者之间的相互作用,并建议未来的回顾性研究来验证这些观察结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic.

Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic.

Background: COVID-19 has made itself known to health care providers and families across the world in a matter of months. While primarily a respiratory disorder, it has also been shown to cause neurological symptoms, which can be a concern for Parkinson's disease (PD) patients. Although PD is not as common as other conditions such as cardiovascular diseases, it affects millions of patients around the world whose care has been affected by the global pandemic.

Objectives: The aim of this review is to provide insight into the direct and indirect associations between COVID-19 and PD patient care.

Results: Potential direct effects of COVID-19 include possible neurodegeneration, concerns of symptom self-management with over-the-counter (OTC) products and ICU challenges that can arise in PD patients. In addition, a subset of PD patients may be at higher risk of severe COVID-19 infection. The indirect effects of the pandemic are associated with the social distancing measures and disruptions in health care systems and PD clinical trials, which may negatively affect PD patients' mental wellbeing and create barriers in controlling their PD symptoms. On a more positive note, telemedical care is quickly emerging as a primary communication tool for virtual patient care. However, further research should be conducted to examine the applicability of telemedicine across the entire PD population, such as those with more severe symptoms living in less developed areas. With all the uncertainty during this time, it is hopeful to hear many promising COVID-19 treatments being researched, one of them being a PD drug therapy, amantadine.

Conclusion: Hopefully, we can consider this pandemic an opportunity to strengthen the PD community and learn more about the impact of the SARS-COV-2 virus. This review provides an overview of the interaction between COVID-19 and PD patients and future investigational retrospective studies are suggested to validate the observations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信